-
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
2018 Jul 13, 4:41pmRead More...This week, Tilray and Sproutly Canada went public, Sunniva announced plans to spin off its Canadian assets, Zynerba Pharmaceuticals posted positive data for its Phase 2 trial for ZYN002 in Fragile X syndrome, and Zogenix released positive top-line results from its second pivotal Phase 3 study...
-
30 Stocks Moving In Friday's Mid-Day Session
2018 Jul 13, 12:38pmRead More...Gainers Biocept Inc (NASDAQ: BIOC) climbed 66 percent to $10.87 following announcement of marketing & distribution agreement for its biopsy tests with Alliance Global FZ for the Middle East, Southeast Asia and Africa regions. ShiftPixy, Inc. (NASDAQ: PIXY) shares gained 49.8 percent to $4.105...
-
24 Stocks Moving In Friday's Mid-Day Session
2018 Jul 13, 8:03amRead More...Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 33.2 percent to $3.65 in pre-market trading after the company issued upbeat guidance for the third quarter. ObsEva SA (NASDAQ: OBSV) rose 18.9 percent to $17.75 in pre-market trading. ObsEva will begin trading today on the SIX Swiss Exchange....
-
-
44 Biggest Movers From Yesterday
2018 Jul 13, 4:08amRead More...Gainers Izea Inc (NASDAQ: IZEA) surged 173.65 percent to close at $2.56 on Thursday after the company reported a deal to buy TapInfluence for $7.08 million in cash and stock. China TechFaith Wireless Communication Technology Limited (NASDAQ: CNTF) shares rose 63.93 percent to close at $3.00 after...
-
30 Stocks Moving In Thursday's Mid-Day Session
2018 Jul 12, 12:19pmRead More...Gainers Izea Inc (NASDAQ: IZEA) jumped 89.2 percent to $1.77 after the company reported a deal to buy TapInfluence for $7.08 million in cash and stock. China TechFaith Wireless Communication Technology Limited (NASDAQ: CNTF) shares gained 86.4 percent to $3.41 after the company agreed to sell its...
-
Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study
2018 Jul 12, 8:47amRead More...Zogenix, Inc. (NASDAQ: ZGNX) peaked nearly 30 percent in Thursday's pre-market session after management released positive top-line results from its second pivotal Phase 3 study of ZX008 in Dravet Syndrome. The trial met primary and secondary endpoints and demonstrated statistical significance...
-
Zynerba Pops On Positive Phase 2 Data For ZYN002 In Fragile X
2018 Jul 12, 8:14amRead More...Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) announced Thursday its Phase 2 trial for ZYN002 in Fragile X syndrome found sustained improvements in patients’ core behavioral symptoms. The drug was well tolerated with no serious adverse events. Why It’s Important The candidate is the most...
-
25 Stocks Moving In Thursday's Pre-Market Session
2018 Jul 12, 8:00amRead More...Gainers Izea Inc (NASDAQ: IZEA) rose 191 percent to $2.72 in pre-market trading after the company reported a deal to buy TapInfluence for $7.08 million in cash and stock. China TechFaith Wireless Communication Technology Limited (NASDAQ: CNTF) shares rose 132.2 percent to $4.25 in pre-market...
-
44 Biggest Movers From Yesterday
2018 Jul 12, 4:00amRead More...Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 115.22 percent to close at $7.92 on Wednesday. MYOS RENS Technology Inc. (NASDAQ: MYOS) climbed 38.19 percent to close at $1.99 on Wednesday. AC Immune SA (NASDAQ: ACIU) jumped 21.52 percent to close at $16.04. Arbutus Biopharma Corporation (...
-
6 Stocks Moving In Wednesday's After-Hours Session
2018 Jul 11, 4:58pmRead More...Gainers CA, Inc. (NASDAQ: CA) shares are up 16 percent following reports Broadcom Inc (NASDAQ: AVGO) is near a deal to buy the company for $4.50 per share; Broadcom shares are down 5 percent after hours. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) shares are up 12 percent after Cantor...
-
resTORbio Spikes Higher Following Positive Phase 2 Data
2018 Jul 11, 3:45pmRead More...resTORbio, Inc. (NASDAQ: TORC) announced Wednesday its TORC1 inhibitor treatment demonstrated targeted improvements in a Phase 2a clinical trial. The study cohort, composed of patients 65 years and older, reported clinically meaningful reductions in the incidence of infections as well as...
-
Papa John's Founder Resigns Following Backlash Of His Racial Slur
2018 Jul 11, 1:10pmRead More...UPDATE: Schnatter resigned as chairman of Papa John's late Wednesday night. The company said in a statement they will appoint a chairman in the coming weeks. Papa John's International, Inc. (NYSE: PZZA) founder and chairman John Schnatter has been heavy in the limelight this past year. And...
-
38 Stocks Moving In Wednesday's Mid-Day Session
2018 Jul 11, 12:35pmRead More...Gainers Medigus Ltd. (NASDAQ: MDGS) shares jumped 68.6 percent to $2.0901. Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares jumped 33.8 percent to $4.8301 after the company reported advancement of cytisine development program following a meeting with the FDA. MYOS RENS Technology Inc. (NASDAQ:...
-
25 Stocks Moving In Wednesday's Pre-Market Session
2018 Jul 11, 8:05amRead More...Gainers Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares rose 50.2 percent to $5.42 in pre-market trading after the company reported advancement of cytisine development program following a meeting with the FDA. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL) shares rose 27.1 percent to $3.47 in...
-
41 Biggest Movers From Yesterday
2018 Jul 11, 4:38amRead More...Gainers MER Telemanagement Solutions Ltd. (NASDAQ: MTSL) shares jumped 145.95 percent to close at $2.73 on Tuesday. Bridgeline Digital, Inc. (NASDAQ: BLIN) surged 75.57 percent to close at $2.30 on Tuesday after the company reported a digital platform contract with a full-service bank. U.S. Gold...
